BrenX Cuts Losses 18%, Hits Key Milestones in Shift to Energy Infrastructure
BRNX is trading near its 52-week low of $2.062 (14% above the low) on elevated volume (2.2× avg).
Summary
BrenX reported H1 2026 results with net loss down 18% to $6.09M and operating loss down 9% to $5.97M, though revenue fell to zero from $387K a year ago. Cash stands at $5.69M. The company hit major operational milestones: its 32 MWh bGen system at Tempo is producing steam during commissioning, and it received a construction permit and started work on a 12 MWh system at Wolfson Medical Center. It also acquired a 1.2 MWp operating solar facility in Hungary for ~$1.1M and signed a deal to buy adjacent land for its first integrated energy resource center. Baran Energy agreed to buy the Tempo and Wolfson systems for ~$2.9M in milestone payments, providing near-term revenue. The rebrand to BrenX and ticker change to BRNX reflect the shift from equipment sales to owning and operating energy infrastructure. This follows the August capital raises and F-3 registration, which created a significant share overhang. The company is still burning cash but has enough runway to execute near-term projects; the Hungary expansion and Baran payments are the next catalysts.
Updates
· SEC 6-K — The 6-K includes unaudited condensed consolidated financial statements and MD&A for the six months ended June 30, 2026, with total assets of $13.48M, total liabilities of $8.88M, and shareholders' equity of $4.59M.
At the time of this announcement, BRNX was trading at $2.34 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $2.06 to $512.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: TMX Newsfile.